The Pharmacovigilance and Special Access Branch (PSAB) of the TGA has recently drafted a revision of the Australian requirements and recommendations for pharmacovigilance responsibilities of sponsors of medicines, also known as the Pharmacovigilance Guidelines.

CMA members are invited to participate in a targeted consultation for this revision Please provide your feedback via email to submissions@cmaustralia.org.au by close of business Friday 14 July 2017.

Click here to read more.